DOI: 10.1055/s-00025479

Experimental and Clinical Endocrinology & Diabetes Reports



Puig-Domingo M, Soto A, Venegas E. et al.
Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: The ACROCOMB study.

Endocrinol Nutr 2016;
63: 397-408

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: